Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Mayr

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Cancers|August 7, 2021
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract CancerChristian Mayr, Tobias Kiesslich, Sara Erber, et al.
Cells|February 26, 2020
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center ExperienceDaniel Neureiter, Christian Mayr, Paul Winkelmann, et al.
Human Pathology|February 26, 2017
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcomeEckhard Klieser, Romana Urbas, Stefan Stättner, et al.
Molecular and Cellular Biochemistry|July 28, 2014
Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancerTobias Kiesslich, Christian Mayr, Julia Wachter, et al.
International Journal of Molecular Sciences|October 17, 2018
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor CellsJulia Wanek, Martin Gaisberger, Marlena Beyreis, et al.
Plos One|June 30, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cellsChristian Mayr, Tobias Kiesslich, Dino Bekric, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Cancer Biology & Therapy|December 13, 2024
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancerCelina Ablinger, Daniel Neureiter, Theresa Mähr, et al.
Human Pathology|November 15, 2017
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancerChristian Mayr, Katharina Helm, Martin Jakab, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Cancers|August 7, 2021
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract CancerChristian Mayr, Tobias Kiesslich, Sara Erber, et al.
Cells|February 26, 2020
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center ExperienceDaniel Neureiter, Christian Mayr, Paul Winkelmann, et al.
Human Pathology|February 26, 2017
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcomeEckhard Klieser, Romana Urbas, Stefan Stättner, et al.
Molecular and Cellular Biochemistry|July 28, 2014
Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancerTobias Kiesslich, Christian Mayr, Julia Wachter, et al.
International Journal of Molecular Sciences|October 17, 2018
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor CellsJulia Wanek, Martin Gaisberger, Marlena Beyreis, et al.
Plos One|June 30, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cellsChristian Mayr, Tobias Kiesslich, Dino Bekric, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Cancer Biology & Therapy|December 13, 2024
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancerCelina Ablinger, Daniel Neureiter, Theresa Mähr, et al.
Human Pathology|November 15, 2017
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancerChristian Mayr, Katharina Helm, Martin Jakab, et al.
Pageof 8